Inactive Instrument

Analyst Reco. Icosavax, Inc.

Equities

Guggenheim Downgrades Icosavax to Neutral From Buy	Jan. 02	MT
FTSE 100 Edges Higher as European Markets Remain Cautious Ahead of Rate Calls	Dec. 13	DJ
Jefferies Downgrades Icosavax to Hold From Buy, Cuts Price Target to $15.50 From $30	Dec. 12	MT
London Stocks Flat as Markets Digest UK Wage Data, Upcoming Rate Decisions	Dec. 12	MT
William Blair Downgrades Icosavax to Market Perform From Outperform	Dec. 12	MT
FTSE 100 hits 8-week high on slowing wage growth, but construction sector drags	Dec. 12	RE
Guggenheim Starts Icosavax With Buy Rating, $28 Price Target	Nov. 17	MT
Oppenheimer Adjusts Icosavax Price Target to $25 From $27, Maintains Outperform Rating	23-05-24	MT
Oppenheimer Initiates Coverage on Icosavax With Outperform Rating, $27 Price Target	23-01-04	MT
Evercore ISI Raises Icosavax to Outperform From In-Line, Price Target to $18 From $10	22-06-30	MT
Evercore ISI Downgrades Icosavax to In-Line From Outperform	22-03-25	MT
Icosavax : Shares Gain After Analysts Initiate Coverage	21-08-23	MT
ICOSAVAX : Evercore ISI Initiates Coverage on Icosavax With Outperform Rating, $50 Price Target	21-08-23	MT
ICOSAVAX : Jefferies Initiates Coverage on Icosavax With Buy Rating, $50 Price Target	21-08-23	MT
ICOSAVAX : Cowen Initiates Coverage on Icosavax With Outperform Rating	21-08-23	MT
ICOSAVAX : William Blair Initiates Coverage on Icosavax With Outperform Rating	21-08-23	MT

No results for this search